According to InnovAge's latest financial reports the company's current revenue (TTM) is $0.72 B. In 2022 the company made a revenue of $0.68 B an increase over the years 2021 revenue that were of $0.67 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.72 B | 4.63% |
2022 | $0.68 B | 1.86% |
2021 | $0.67 B | 11.4% |
2020 | $0.60 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Merck MRK | $60.11 B | 8,239.95% | ๐บ๐ธ USA |
Cocrystal Pharma
COCP | N/A | N/A | ๐บ๐ธ USA |
AcelRx Pharmaceuticals
ACRX | $0.65 M | -99.91% | ๐บ๐ธ USA |
Horizon Therapeutics
HZNP | $3.64 B | 405.61% | ๐ฎ๐ช Ireland |